Clinical Trials Browser

Phase 1/2 × Ribavirin × 1 year × Clear all

NCT01309490 2025-07-29

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor